Omega Healthcare Investors (OHI) Depreciation & Amortization (CF) (2009 - 2026)

Omega Healthcare Investors has disclosed Depreciation & Amortization (CF) across 16 years of filings, most recently posting $84.1 million for Q1 2026.

• Depreciation & Amortization (CF) for Q1 2026 came in at $84.1 million, up 5.34% year-over-year; the trailing twelve-month figure through Mar 2026 was $329.5 million (up 6.31% YoY), and the FY2025 annual result was $325.2 million, up 6.76% from the prior year.
• Depreciation & Amortization (CF) came in at $84.1 million for Q1 2026 at Omega Healthcare Investors, up from $82.7 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $84.1 million in Q1 2026 to a low of $74.2 million in Q2 2024.
• The 5-year median for Depreciation & Amortization (CF) is $81.2 million (2023), against an average of $80.4 million.
• Across the five-year window, Depreciation & Amortization (CF) slipped 9.63% in 2023 and gained 8.45% in 2025, its largest moves.
• Omega Healthcare Investors' Depreciation & Amortization (CF) stood at $83.7 million in 2022, then declined by 9.63% to $75.7 million in 2023, then grew by 3.88% to $78.6 million in 2024, then advanced by 5.26% to $82.7 million in 2025, then rose by 1.68% to $84.1 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $84.1 million (Q1 2026), $82.7 million (Q4 2025), and $82.1 million (Q3 2025), per Business Quant data.